Managing Pharmacovigilance Challenges for Biosimilars

As the global biosimilars market rapidly expands, effective pharmacovigilance (PV) systems are more critical than ever to ensuring the safety and efficacy of these complex drugs. This article by Ivana Lisec, Vice President/Business Unit Lead, Generics, Hybrids and Biosimilars at PrimeVigilance, explores the challenges of managing PV for biosimilars and provides expert-driven solutions for success. 

 

Download this free article to learn: 

• The unique regulatory requirements for biosimilars 
• How to balance cost and quality in biosimilar development 
• Strategies for ensuring safety across the biosimilar life cycle

 

Read this article for practical, actionable advice for biosimilar developers navigating the complexities of pharmacovigilance in today’s market. 

 

Please enter your details to get access to the content